Can we treat anti‐PD1 induced psoriasis in patients with active cancer with biologic therapy? Report of three cases

Can we treat anti‐PD1 induced psoriasis in patients with active cancer with biologic therapy? Report of three cases

Bibliographic Details
Main Authors:	Pedro Rodríguez‐Jiménez, Ander Mayor Ibarguren, Beatriz Butrón‐Bris, Luisa Martos‐Cabrera, Mar Llamas‐Velasco
Format:	Article
Language:	English
Published:	Wiley 2023-06-01
Series:	JEADV Clinical Practice
Online Access:	https://doi.org/10.1002/jvc2.130

Similar Items

Biological treatment, vaccines, and viral infections in immune-mediated inflammatory diseases
by: Beatriz Butrón-Bris, et al.
Published: (2022-04-01)

First experiences in real clinical practice treating a patient with generalised pustular psoriasis with Spesolimab
by: Aurora Fernández‐Galván, et al.
Published: (2023-06-01)

Psoriasis Therapy and Skin Cancer: A Review
by: Beatriz Butrón-Bris, et al.
Published: (2021-10-01)

Umbilical lichen planus induced by nivolumab
by: Luisa Martos-Cabrera, et al.
Published: (2023-08-01)

Pharmacogenetics Update on Biologic Therapy in Psoriasis
by: Ester Muñoz-Aceituno, et al.
Published: (2020-12-01)

Escasa relevancia clínica en los parches positivos a limoneno y/o linalool en 247 pacientes consecutivos con eccema
by: M. Llamas-Velasco, et al.
Published: (2024-03-01)

[Translated article] Low Clinical Relevance of Positive Patch Test Reactions to Limonene and/or Linalool Hydroperoxides in 247 Consecutive Patients with Eczema
by: M. Llamas-Velasco, et al.
Published: (2024-03-01)

Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
by: Ander Mayor Ibarguren, MD, et al.
Published: (2021-05-01)

The Impact of Biologic Treatment on PD-1/PD-L1 Pathway Disturbances in Psoriasis
by: Michał Adamczyk, et al.
Published: (2023-06-01)

A New Classification of the Severity of Psoriasis: What’s Moderate Psoriasis?
by: Laura Salgado-Boquete, et al.
Published: (2021-06-01)

Psoriasis in areas difficult to treat and biological therapy
by: Anna Lis-Święty, et al.
Published: (2021-08-01)

A Hypothesis for the Possible Role of Zinc in the Immunological Pathways Related to COVID-19 Infection
by: Ander Mayor-Ibarguren, et al.
Published: (2020-07-01)

Immune checkpoint inhibitor‐mediated psoriasis treated with biologics
by: Pei Ming Yeo, et al.
Published: (2023-06-01)

How can we estimate early relapsed follicular lymphoma and how can we treat?
by: Ozan Salim
Published: (2020-10-01)

Can We Treat Neuroinflammation in Alzheimer’s Disease?
by: Sandra Sánchez-Sarasúa, et al.
Published: (2020-11-01)

The economic burden and quality of life of patients with psoriasis treated with biologics in China
by: Shuhui Min, et al.
Published: (2023-12-01)

Sparing of injection sites in patients with extensive psoriasis treated with various biologics
by: Ya-Chu Tsai, et al.
Published: (2019-01-01)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
by: Merav Koschitzky, BA, et al.
Published: (2021-05-01)

Can we really treat mentally ill patients involuntarily?
by: J. Gonçalves Cerejeira, et al.
Published: (2022-06-01)

Water, agriculture and the environment in Spain : can we square the circle? /
by: De Stefano, Lucia, et al.
Published: (2013)

Obesidad: factor de riesgo para psoriasis y COVID-19
by: M. Llamas-Velasco, et al.
Published: (2021-06-01)

Strategy “treat to target” for patients with psoriasis. Relevant issues to biological therapy persistence
by: A. L. Bakulev
Published: (2017-08-01)

Biological treatment of psoriasis
by: Sylwia Słuczanowska-Głąbowska, et al.
Published: (2022-08-01)

Biologics in the management of psoriasis
by: Jennifer D Bahner, et al.
Published: (2009-07-01)

Infective endocarditis – can we treat it more effectively?
by: Aneta Guzek, et al.
Published: (2020-04-01)

Investigation of the PD-1/PD-L1 Expression in the Lesional Skins of Patients with Psoriasis
by: Selma Emre, et al.
Published: (2023-04-01)

Evidence and suggested therapeutic approach in psoriasis of difficult-to-treat areas: Palmoplantar psoriasis, nail psoriasis, scalp psoriasis, and intertriginous psoriasis
by: Nilendu Sarma
Published: (2017-01-01)

Can We Learn to Treat One Another Better? A Test of a Social Intelligence Curriculum.
by: Eva K Zautra, et al.
Published: (2015-01-01)

Can Biologic Agents Improve Treatment Success in Obese Patients With Psoriasis Vulgaris: A Retrospective Review of 320 Patients With Psoriasis Vulgaris
by: Atıl Avcı, et al.
Published: (2024-01-01)

Early intervention in psoriasis: Where do we go from here?
by: Paulo Antônio Oldani Felix, et al.
Published: (2022-12-01)

Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016-09-01)

Time to relapse after treatment withdrawal for different biologics used to treat plaque psoriasis
by: Xiao-Yu Wang, et al.
Published: (2020-12-01)

Opioids in prison: can we reduce their use?
by: J. Velasco Montes, et al.

Epidemiology of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents
by: Emanuel Marques, et al.
Published: (2022-04-01)

Methotrexate Management in Psoriasis: Are We Following the Guidelines?
by: Tora Lindqvist, et al.
Published: (2018-01-01)

Accommodating autistics and treating autism : can we have both?
by: Lim, Chong-Ming
Published: (2020)

Can we treat retinopathy of prematurity under topical anesthesia?
by: Nouf Al-Farsi, et al.
Published: (2021-01-01)

Can we treat secondary progressive multiple sclerosis now?
by: Rohit Bhatia, et al.
Published: (2019-01-01)

Biological therapies in psoriasis - revisited
by: Sârbu Maria-Isabela, et al.
Published: (2018-06-01)

The other side of biologics for psoriasis
by: Chao-Chun Yang
Published: (2022-01-01)